| BCBS Kansas City Medical Policies | Pharmacologic Treatment of Hereditary Transthyretin-Mediated Amyloidosis (Onpattro™/Tegsedi™/Amvuttra™) | |
| BCBS Kansas City Medical Policies | Genicular Nerve Blocks and Ablation for Chronic Knee Pain | |
| BCBS Kansas City Medical Policies | Cemiplimab-rwlc (Libtayo®) | |
| BCBS Kansas City Medical Policies | Hospice Care | |
| BCBS Kansas City Medical Policies | Genetic Testing for Neurodegenerative Disorders | |
| BCBS Kansas City Medical Policies | Laboratory Guideline Policy | |
| BCBS Kansas City Medical Policies | Therapeutic Drug Monitoring for 5-Fluorouracil | |
| BCBS Kansas City Medical Policies | Speech Generating Devices | |
| BCBS Kansas City Medical Policies | Proteogenomic Testing of Individuals With Cancer | |
| BCBS Kansas City Medical Policies | Crizanlizumab-tmca (Adakveo) | |